PC-21

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePC-21
Drug Alias NamePC-21
ClassificationBiologics
Mechanisms of ActionCyclin-dependent kinase 4 inhibitors
TargetsCyclin-dependent kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesProcell Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcell Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A